123 related articles for article (PubMed ID: 26527865)
1. Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting.
Hong J; Novick D; Montgomery W; Moneta MV; Dueñas H; Peng X; Haro JM
Patient Prefer Adherence; 2015; 9():1481-90. PubMed ID: 26527865
[TBL] [Abstract][Full Text] [Related]
2. Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Hong J; Novick D; Montgomery W; Moneta MV; Dueñas H; Peng X; Haro JM
Asia Pac Psychiatry; 2016 Mar; 8(1):51-9. PubMed ID: 25808275
[TBL] [Abstract][Full Text] [Related]
3. Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Novick D; Montgomery W; Haro JM; Moneta MV; Zhu G; Yue L; Hong J; Dueñas H; Brugnoli R
Neuropsychiatr Dis Treat; 2016; 12():383-92. PubMed ID: 26966361
[TBL] [Abstract][Full Text] [Related]
4. Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study.
Novick D; Hong J; Montgomery W; Dueñas H; Gado M; Haro JM
Neuropsychiatr Dis Treat; 2015; 11():197-205. PubMed ID: 25653529
[TBL] [Abstract][Full Text] [Related]
5. An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.
Kuga A; Tsuji T; Hayashi S; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
Neuropsychiatr Dis Treat; 2017; 13():2115-2124. PubMed ID: 28831260
[TBL] [Abstract][Full Text] [Related]
6. Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study.
Dueñas H; Lee A; Brnabic AJ; Chung KF; Lai CH; Badr MG; Uy-Ponio T; Ruiz JR; Varrey P; Jian H; Dossenbach M
Int J Psychiatry Clin Pract; 2011 Jun; 15(2):80-90. PubMed ID: 22121855
[TBL] [Abstract][Full Text] [Related]
7. Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East.
Hong J; Novick D; Moneta MV; El-Shafei A; Dueñas H; Haro JM
Clin Pract Epidemiol Ment Health; 2017; 13():145-155. PubMed ID: 29238391
[TBL] [Abstract][Full Text] [Related]
8. An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis.
Kuga A; Tsuji T; Hayashi S; Matsubara M; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
Neuropsychiatr Dis Treat; 2017; 13():2105-2114. PubMed ID: 28831259
[TBL] [Abstract][Full Text] [Related]
9. Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period.
Dueñas H; Brnabic AJ; Lee A; Montejo AL; Prakash S; Casimiro-Querubin ML; Khaled M; Dossenbach M; Raskin J
Int J Psychiatry Clin Pract; 2011 Nov; 15(4):242-54. PubMed ID: 22121997
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline.
Huang J; Wang Y; Chen J; Zhang Y; Yuan Z; Yue L; Haro JM; Moneta MV; Novick D; Fang Y
Neuropsychiatr Dis Treat; 2018; 14():2473-2484. PubMed ID: 30310285
[TBL] [Abstract][Full Text] [Related]
12. Chinese patients with major depression: Do concomitant pain symptoms affect quality of life independently of severity of depression?
Novick D; Montgomery W; Moneta MV; Peng X; Brugnoli R; Haro JM
Int J Psychiatry Clin Pract; 2015; 19(3):174-81. PubMed ID: 25946899
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
14. Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
Novick D; Montgomery W; Kadziola Z; Moneta V; Peng X; Brugnoli R; Haro JM
Patient Prefer Adherence; 2013; 7():463-70. PubMed ID: 23818764
[TBL] [Abstract][Full Text] [Related]
15. Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy.
Noto S; Wake M; Mishiro I; Hammer-Helmich L; Ren H; Moriguchi Y; Fujikawa K; Fernandez J
Value Health Reg Issues; 2022 Jul; 30():127-133. PubMed ID: 35405582
[TBL] [Abstract][Full Text] [Related]
16. [Results of the French cohort of the European observational study FINDER: quality of life of patients treated with antidepressants].
Dantchev N; Tcherny-Lessenot S; Picard H; Baraille L; Quail D
Encephale; 2013 Apr; 39(2):101-8. PubMed ID: 23095580
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
[TBL] [Abstract][Full Text] [Related]
19. Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study.
Woo JM; Jeon HJ; Noh E; Kim HJ; Lee SW; Lee KK; Kim SH; Hong JP
Health Qual Life Outcomes; 2014 Dec; 12():188. PubMed ID: 25519704
[TBL] [Abstract][Full Text] [Related]
20. Switching to duloxetine from selective serotonin reuptake inhibitors in non- or partial responders: Results from a Spanish sample.
Irene R; Luis MA; Helena DC; David P; Ramon DJ; Inmaculada G
Int J Psychiatry Clin Pract; 2009; 13(2):100-8. PubMed ID: 24916728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
